Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant kawasaki disease: A prospective study

Pediatric Cardiology

Volumn 34, Issue 4, 2013, Pages 959-963

  Teraguchi, Masayuki ^a,b   Ogino, Hirotaro ^a   Yoshimura, Ken ^a   Taniuchi, Shoichiro ^a   Kino, Minoru ^b   Okazaki, Hitoshi ^c   Kaneko, Kazunari ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Nakano Children's Hospital   (Japan)

^c KAWACHI GENERAL HOSPITAL   (Japan)

Author keywords

Intravenous immunoglobulin therapy resistant; Kawasaki disease; Prospective study; Steroid pulse therapy

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ALBUMIN BLOOD LEVEL; ARTERY LESION; ARTICLE; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CORONARY ARTERY LESION; DRUG PULSE THERAPY; FEMALE; HEALTH CARE COST; HUMAN; IMMUNOTHERAPY; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ALBUMINS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; PULSE THERAPY, DRUG; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84879499529     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0589-9     Document Type: Article

References (16)

1. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 7:1144-1148
2. Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y (2008) Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child 93:142-146
3. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Baba K, Mori C (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 10:1055-1058
4. Hashino K, Ishii M, Iemura M, Akagi T, Kato H (2001) Retreatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 43:211-217
5. Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A (2006) A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 149:336-341
6. Kato H, Koike S, Yokoyama T (1979) Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 63:175-179
7. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271-276
8. Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, Yamagishi H (2005) Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease. Arch Dis Child 90:1096-1097
9. Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M (2008) Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin. Eur J Pediatr 167:1119-1123
10. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747-2471
11. Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP (2007) Pediatric heart network investigators. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 356:663-675
12. Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M (2009) The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol 53:15-19
13. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, Morikawa A (2003) Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143:363-367
14. Research Committee on Kawasaki Disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo
15. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y (2003) Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 108:325-330
16. Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrcs 105:e78